| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327386 | Gynecologic Oncology | 2005 | 5 Pages |
Abstract
Adjuvant ifosfamide and cisplatin after primary surgery for stage I or II carcinosarcoma of the uterus is tolerable. In the absence of concurrent controls, the impact on PFS and OS is unclear. Pelvic relapse remains problematic.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Gregory Sutton, James Kauderer, Linda F. Carson, Samuel S. Lentz, Charles W. Whitney, Holly Gallion,